Plain-English translation of NCT07694440 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it can help adults with phenylketonuria (PKU)—a genetic condition that makes it hard for your body to break down a protein building block called phenylalanine. The study will check whether the medication is safe to take and whether it helps lower phenylalanine levels in your blood.
PKU is a lifelong condition that requires careful diet management to prevent serious health problems. This medication is being developed to offer a new treatment option that might help people manage their condition more easily.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the new medication at a low or high dose, or a placebo (a pill with no active ingredient), and would take your assigned treatment by mouth. Throughout the study, you'll have regular clinic visits where your blood will be tested to measure phenylalanine levels and check how well you're tolerating the medication. The study will monitor your safety and how effectively the treatment works over time.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
United States